Go Pro
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
$4.96
-6.4%		$7.56
$4.19
▼
$18.79
$139.91MN/A229,000 shs608,439 shs
Inogen, Inc stock logo
INGN
Inogen
$5.14
+0.2%		$5.87
$5.05
▼
$9.13
$136.41M1.57258,036 shs438,972 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.77
+1.4%		$0.79
$0.63
▼
$2.57
$35.68M0.83143,852 shs19,862 shs
Owlet, Inc. stock logo
OWLT
Owlet
$4.71
+3.8%		$5.33
$4.19
▼
$16.94
$138.51M1.9219,488 shs546,114 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
0.00%+11.21%-47.40%-62.65%+495,999,900.00%
Inogen, Inc stock logo
INGN
Inogen
0.00%-3.20%-8.21%-19.81%-38.22%
InspireMD, Inc. stock logo
NSPR
InspireMD
0.00%-2.85%-14.72%+8.08%-68.03%
Owlet, Inc. stock logo
OWLT
Owlet
0.00%+0.58%-16.16%-5.85%-36.63%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
$4.96
-6.4%		$7.56
$4.19
▼
$18.79
$139.91MN/A229,000 shs608,439 shs
Inogen, Inc stock logo
INGN
Inogen
$5.14
+0.2%		$5.87
$5.05
▼
$9.13
$136.41M1.57258,036 shs438,972 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.77
+1.4%		$0.79
$0.63
▼
$2.57
$35.68M0.83143,852 shs19,862 shs
Owlet, Inc. stock logo
OWLT
Owlet
$4.71
+3.8%		$5.33
$4.19
▼
$16.94
$138.51M1.9219,488 shs546,114 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
0.00%+11.21%-47.40%-62.65%+495,999,900.00%
Inogen, Inc stock logo
INGN
Inogen
0.00%-3.20%-8.21%-19.81%-38.22%
InspireMD, Inc. stock logo
NSPR
InspireMD
0.00%-2.85%-14.72%+8.08%-68.03%
Owlet, Inc. stock logo
OWLT
Owlet
0.00%+0.58%-16.16%-5.85%-36.63%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
2.00
Hold$20.00303.23% Upside
Inogen, Inc stock logo
INGN
Inogen
2.50
Moderate BuyN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.50486.40% Upside
Owlet, Inc. stock logo
OWLT
Owlet
2.40
Hold$15.00218.34% Upside

Current Analyst Ratings Breakdown

Latest NSPR, INGN, OWLT, and CNXU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/10/2026
Owlet, Inc. stock logo
OWLT
Owlet
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/17/2026
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageSell (E-)
8/13/2026
Owlet, Inc. stock logo
OWLT
Owlet
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/5/2026
Inogen, Inc stock logo
INGN
Inogen
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/31/2026
Owlet, Inc. stock logo
OWLT
Owlet
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/29/2026
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
6/22/2026
Owlet, Inc. stock logo
OWLT
Owlet
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$13.00 ➝ $10.00
6/22/2026
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$20.00
(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/A$0.21 per shareN/A
Inogen, Inc stock logo
INGN
Inogen
$348.67M0.39N/AN/A$7.08 per share0.73
InspireMD, Inc. stock logo
NSPR
InspireMD
$10.84M3.29N/AN/A$1.83 per share0.42
Owlet, Inc. stock logo
OWLT
Owlet
$105.70M1.30N/AN/A$0.71 per share6.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
-$3.92M-$0.11N/AN/AN/AN/A-200.20%-177.26%N/A
Inogen, Inc stock logo
INGN
Inogen
-$22.75M-$0.90N/AN/AN/A-6.94%-13.17%-8.36%11/4/2026 (Estimated)
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.64N/AN/AN/A-413.96%-69.42%-57.68%N/A
Owlet, Inc. stock logo
OWLT
Owlet
-$39.68M-$0.75N/AN/AN/A-8.61%-601.24%-15.96%11/12/2026 (Estimated)

Latest NSPR, INGN, OWLT, and CNXU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/14/2026Q3 2026
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
-$0.10-$0.29-$0.19-$0.29N/AN/A
8/11/2026Q2 2026
Owlet, Inc. stock logo
OWLT
Owlet
-$0.09-$0.05+$0.04-$0.05$31.71 million$33.87 million
8/6/2026Q2 2026
Inogen, Inc stock logo
INGN
Inogen
-$0.1533-$0.14+$0.0133-$0.14$95.23 million$95.08 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Owlet, Inc. stock logo
OWLT
Owlet
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
5.31
14.93
Inogen, Inc stock logo
INGN
Inogen
N/A
2.74
2.34
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Owlet, Inc. stock logo
OWLT
Owlet
N/A
1.64
1.35

Institutional Ownership

CompanyInstitutional Ownership
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
Inogen, Inc stock logo
INGN
Inogen
89.94%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Owlet, Inc. stock logo
OWLT
Owlet
72.60%

Insider Ownership

CompanyInsider Ownership
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
Inogen, Inc stock logo
INGN
Inogen
2.50%
InspireMD, Inc. stock logo
NSPR
InspireMD
24.98%
Owlet, Inc. stock logo
OWLT
Owlet
36.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
428.21 millionN/AN/A
Inogen, Inc stock logo
INGN
Inogen
75326.54 million25.88 millionOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
12746.49 million18.33 millionOptionable
Owlet, Inc. stock logo
OWLT
Owlet
11429.22 million18.65 millionNo Data

Recent News About These Companies

Owlet, Inc. (NYSE:OWLT) Receives Consensus Recommendation of "Hold" from Analysts
September 17 at 2:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31027962
Owlet, Inc. (NYSE:OWLT) Given Consensus Recommendation of "Hold" by Analysts
September 17 at 2:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-owlet-inc-nyse-owlt-given-consensus-recommendation-of-hold-by-analysts-2026-09-17/
Owlet: The Business Is Growing, But The Stock Isn't
September 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4943202-owlet-the-business-is-growing-but-the-stock-isnt
AWM Investment Company Inc. Buys Shares of 1,225,353 Owlet, Inc. $OWLT
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-awm-investment-company-inc-buys-shares-of-1225353-owlet-inc-owlt-2026-08-26/
Owlet, Inc. (NYSE:OWLT) Given Average Rating of "Hold" by Analysts
August 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/owlet-inc-nyseowlt-given-average-rating-of-hold-by-analysts-2026-08-23/
Owlet: High Risk, High Reward In Medical Tech And Subscription
August 21, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4939198-owlet-high-risk-high-reward-in-medical-tech-and-subscription
Owlet Stockholders Approve 2026 Governance and Incentive Plans
August 14, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/owlet-stockholders-approve-2026-governance-and-incentive-plans?utm_source=marketbeat.com&utm_medium=referral
Owlet, Inc. (OWLT) Q2 FY2026 earnings call transcript
August 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/OWLT/earnings/OWLT-Q2-2026-earnings_call-662716.html
Owlet Announces Second Quarter 2026 Financial Results
August 12, 2026  |  joplinglobe.comJ
Owlet, Inc. (OWLT) Q2 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4935081-owlet-inc-owlt-q2-2026-earnings-call-transcript
Owlet, Inc. (OWLT) Q2 Earnings and Revenues Beat Estimates
August 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973111/owlet-inc-owlt-q2-earnings-and-revenues-beat-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2973111
Owlet to Report Second Quarter 2026 Financial Results on August 11, 2026
July 23, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260723247264/en/owlet-to-report-second-quarter-2026-financial-results-on-august-11-2026/
Do Options Traders Know Something About Owlet Stock We Don't?
July 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2951417/do-options-traders-know-something-about-owlet-stock-we-don-t?cid=cs-stocknewsapi-ft-tale_of_the_tape|options-2951417
Northland Securities Remains a Buy on Owlet (OWLT)
July 2, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3100149/northland-securities-remains-a-buy-on-owlet-owlt/
Owlet Secures New Revolving Credit Facility to Expand
July 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/owlet-secures-new-revolving-credit-facility-to-expand?utm_source=marketbeat.com&utm_medium=referral
Owlet (OWLT) Moves 7.3% Higher: Will This Strength Last?
June 19, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2939920/owlet-owlt-moves-7-3-higher-will-this-strength-last?cid=cs-stocknewsapi-ft-tale_of_the_tape|daily_price_change_5%-2939920
Owlet Reschedules 2026 Virtual Annual Stockholders Meeting
June 5, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/owlet-reschedules-2026-virtual-annual-stockholders-meeting?utm_source=marketbeat.com&utm_medium=referral
Owlet to Participate in Upcoming Investor Conferences
May 26, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260526967638/en/owlet-to-participate-in-upcoming-investor-conferences/
Owlet: Telehealth And Subscriptions Could Drive The Next Leg Of Growth
May 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4906006-owlet-telehealth-and-subscriptions-could-drive-the-next-leg-of-growth
Owlet Earnings Call Highlights Subscription-Led Turnaround
May 17, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OWLT/pressreleases/1833052/owlet-earnings-call-highlights-subscription-led-turnaround/
Here’s Why Owlet (OWLT) Crashed 60% in Q1
May 13, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/heres-why-owlet-owlt-crashed-60-despite-its-long-term-growth-opportunity-1757180/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Conexeu Sciences stock logo

Conexeu Sciences NASDAQ:CNXU

$4.96 -0.34 (-6.42%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$5.20 +0.24 (+4.78%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

Inogen stock logo

Inogen NASDAQ:INGN

$5.14 +0.01 (+0.19%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$5.16 +0.02 (+0.39%)
As of 09/18/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

InspireMD stock logo

InspireMD NYSE:NSPR

$0.77 +0.01 (+1.37%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$0.77 +0.00 (+0.08%)
As of 09/18/2026 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Owlet stock logo

Owlet NYSE:OWLT

$4.71 +0.17 (+3.79%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$4.73 +0.02 (+0.38%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas